Trung Quốc ghi nhận thêm 125 ca nhiễm COVID-19, 31 ca tử vong

Ngày 3/3, Trung Quốc đã thông báo có 125 ca nhiễm mới SARS-CoV-2. Đây là mức thấp nhất tính theo ngày về số các ca nhiễm mới trong 6 tuần qua.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Nga công bố 3 lô vaccine ung thư mRNA đầu tiên

Nga công bố 3 lô vaccine ung thư mRNA đầu tiên

Thế giới
(Baothanhhoa.vn) - Nga vừa giới thiệu 3 lô vaccine ung thư thử nghiệm đầu tiên, được phát triển tại Viện Gamaleya ở Moscow, nơi từng tạo ra vaccine COVID-19 Sputnik V. Đây là loại vaccine điều trị ung thư dựa trên công nghệ mRNA, kết hợp trí tuệ nhân tạo (AI) để tùy...
Time vinh danh “Các kiến trúc sư AI” là Nhân vật của Năm 2025

Time vinh danh “Các kiến trúc sư AI” là Nhân vật của Năm 2025

Thế giới
(Baothanhhoa.vn) - Tạp chí Time đã công bố lựa chọn “Architects of AI” (kiến trúc sư AI) là Nhân vật của năm 2025, nhằm ghi nhận tầm ảnh hưởng ngày càng sâu rộng của AI đối với truyền thông, chính trị, kinh tế và nhiều lĩnh vực khác của đời sống. Đây là lần đầu tiên...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh